Design and rationale of the COMPARE‐ACUTE trial: Fractional flow reserve–guided primary multivessel percutaneous coronary intervention to improve guideline indexed actual standard of care for treatment of ST‐elevation myocardial infarction in patients with multivessel coronary disease